Lim Jonathan E

CIK 00012832902 companiesSAN DIEGO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001283290

Recent Transactions

50 trades

Conversion
Erasca, Inc.$ERAS
Series B-1 Preferred Stock
2021-07-20−336,000→ 0 total
Conversion
Erasca, Inc.$ERAS
Common Stock
2021-07-20+5,135,390→ 20,156,222 total
Conversion
Erasca, Inc.$ERAS
Series B-1 Preferred Stock
2021-07-20−336,000→ 0 total
Conversion
Erasca, Inc.$ERAS
Series A Preferred Stock
2021-07-20−6,081,233→ 0 total
Conversion
Erasca, Inc.$ERAS
Series B-2 Preferred Stock
2021-07-20−112,000→ 0 total
Conversion
Erasca, Inc.$ERAS
Series A Preferred Stock
2021-07-20−6,162,468→ 0 total
Conversion
Erasca, Inc.$ERAS
Series B-2 Preferred Stock
2021-07-20−112,000→ 0 total
Conversion
Erasca, Inc.$ERAS
Series A Preferred Stock
2021-07-20−6,162,468→ 0 total
Conversion
Erasca, Inc.$ERAS
Common Stock
2021-07-20+5,441,027→ 11,899,360 total
Conversion
Erasca, Inc.$ERAS
Common Stock
2021-07-20+5,135,390→ 20,156,222 total
Conversion
Erasca, Inc.$ERAS
Common Stock
2021-07-20+5,441,027→ 11,899,360 total
Conversion
Erasca, Inc.$ERAS
Series A Preferred Stock
2021-07-20−6,081,233→ 0 total
Sale
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2007-11-30$8.29/sh−100→ 715,200 total
Sale
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2007-11-30$8.17/sh−602→ 700,900 total
Sale
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2007-11-30$8.30/sh−2,132→ 715,300 total
Sale
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2007-11-30$8.31/sh−2,568→ 717,432 total
Sale
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2007-11-30$8.06/sh−100→ 700,000 total
Sale
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2007-11-30$8.16/sh−800→ 700,100 total
Sale
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2007-11-30$8.30/sh−2,132→ 715,300 total
Exercise/Conversion
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2007-11-30$0.39/sh+20,000→ 720,000 total
Exercise/Conversion
HALOZYME THERAPEUTICS, INC.$HALO
Option to Purchase Common Stock
2007-11-30$0.39/sh−20,000→ 2,182,313 total
Exercise/Conversion
HALOZYME THERAPEUTICS, INC.$HALO
Option to Purchase Common Stock
2007-11-30$0.39/sh−20,000→ 2,182,313 total
Sale
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2007-11-30$8.27/sh−400→ 714,800 total
Sale
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2007-11-30$8.25/sh−5,100→ 709,400 total
Sale
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2007-11-30$8.19/sh−298→ 702,702 total
Sale
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2007-11-30$8.25/sh−5,100→ 709,400 total
Sale
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2007-11-30$8.20/sh−1,440→ 703,000 total
Sale
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2007-11-30$8.18/sh−1,200→ 701,502 total
Sale
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2007-11-30$8.26/sh−300→ 714,500 total
Sale
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2007-11-30$8.17/sh−602→ 700,900 total
Sale
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2007-11-30$8.29/sh−100→ 715,200 total
Sale
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2007-11-30$8.21/sh−3,360→ 704,440 total
Exercise/Conversion
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2007-11-30$0.39/sh+20,000→ 720,000 total
Sale
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2007-11-30$8.20/sh−1,440→ 703,000 total
Sale
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2007-11-30$8.23/sh−1,600→ 707,800 total
Sale
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2007-11-30$8.16/sh−800→ 700,100 total
Sale
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2007-11-30$8.19/sh−298→ 702,702 total
Sale
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2007-11-30$8.18/sh−1,200→ 701,502 total
Sale
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2007-11-30$8.21/sh−3,360→ 704,440 total
Sale
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2007-11-30$8.23/sh−1,600→ 707,800 total
Sale
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2007-11-30$8.26/sh−300→ 714,500 total
Sale
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2007-11-30$8.06/sh−100→ 700,000 total
Sale
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2007-11-30$8.27/sh−400→ 714,800 total
Sale
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2007-11-30$8.31/sh−2,568→ 717,432 total
Exercise/Conversion
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2007-10-16$0.45/sh+26,690→ 700,000 total
Exercise/Conversion
HALOZYME THERAPEUTICS, INC.$HALO
Warrant to Purchase Common Stock
2007-10-16$0.45/sh−26,690→ 2,227,313 total
Exercise/Conversion
HALOZYME THERAPEUTICS, INC.$HALO
Warrant to Purchase Common Stock
2007-10-16$0.45/sh−26,690→ 2,227,313 total
Exercise/Conversion
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2007-10-16$0.45/sh+26,690→ 700,000 total
Sale
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2007-09-28$8.81/sh−1,610→ 689,120 total
Exercise/Conversion
HALOZYME THERAPEUTICS, INC.$HALO
Option to Purchase Common Stock
2007-09-28$0.39/sh−25,000→ 2,254,003 total

Companies

Recent Filings

Address

C/O ERASCA, INC. 10835 ROAD TO THE CURE, SUITE 140

SAN DIEGO, CA, 92121

View on SEC.gov